BD Buys CareFusion For $12.2 Billion
It’s the third largest medtech merger this year, and Becton Dickinson says its purchase of CareFusion will make it a medication management leader and strengthen its role as a hospital solutions provider focused on patient safety.
You may also be interested in...
The US FDA and NIST have agreed to help industry modernize and update pharmaceutical manufacturing methods and to improve supply chain resilience.
Medtronic is sponsoring a trial to evaluate its adaptive deep brain stimulation technology, a unique feature of the Percept PC device for treating Parkinson’s disease.
The company cited lackluster efficacy in its decision to discontinue development of V590 and V591. It will instead develop two drugs to treat COVID-19.